Clinical Trials Sponsored by Xlumena, Inc

Total 35399 results

Xlumena, Inc.

Completed

AXIOS Stent & Delivery System Study

Pancreatic Pseudocyst(s)

United States, Spain
Xlumena, Inc.

Completed

AXIOS Stent With Electrocautery Enhanced Delivery System

Pancreatic Pseudocyst(s)

United States
Lumen Bioscience, Inc.

Completed

Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers

Campylobacter Jejuni Infection

Australia
Ilumens

Completed

Serious Game Versus Online Course to Pre-train Medical Students on the Management of an Adult Cardiac Arrest.

Out-of-Hospital Cardiac Arrest | Simulation Training | Education, Medical, Undergraduate

France
Ilumens

Completed

Repeated Versus Varied Simulation Scenarios to Teach Medical Students the Management of a Pediatric Asthma Exacerbation (REVAR)

Education, Medical

France
Ilumens

Unknown

Are Serious Games Scenarios Specifically Designed for Learning Non Technical Skills More Effective Than Baseline Scenarios in Soft Skills Training

Simulation Training

France
Lumen Bioscience, Inc.

Recruiting

A Study to Determine the Tolerability of Intranasal LMN-301

COVID-19

Australia
Lumen Bioscience, Inc.

Not yet recruiting

LMN-201 for Prevention of C. Difficile Infection Recurrence

Clostridioides Difficile Infection
Lumen Bioscience, Inc.

Not yet recruiting

Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia (AusTD)

Travelers Diarrhea
Lumen Bioscience, Inc.

Completed

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

C. Diff. Infections

Australia
Ilumens

Completed

Computer Debriefing and Screen-based Simulation

Neonatal Resuscitation | Computer Simulation

France
Ilumens

Completed

Comparison of Three Modalities to Assess Clinical Competence of Medical Students (SIMEVAL)

Educational Problems

France
i-Lumen Scientific, Inc.

Recruiting

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) (i-SIGHT)

Age-Related Macular Degeneration | Dry Age-related Macular Degeneration | Nonexudative Age-related Macular Degeneration

United States
i-Lumen Scientific, Inc.

Withdrawn

Microcurrent Stimulation for Dry Age-related Macular Degeneration (i-SIGHT)

Dry Age-related Macular Degeneration
Roswell Park Cancer Institute
Lumeda,Inc.

Active, not recruiting

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Malignant Mesothelioma | Non-Small Cell Lung Carcinoma | Pleural Disorder

United States
Lument AB

Terminated

A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Subjects Referred to CT-examination of the Abdomen

Sweden
Mirum Pharmaceuticals, Inc.
Lumena Pharmaceuticals, Inc.; Childhood Liver Disease Research and Education...

Completed

An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome (IMAGINE-II)

Alagille Syndrome

United States, Canada
Lumen Biomedical

Completed

The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts (RETRIEVE)

Myocardial Ischemia | Embolism | Saphenous Vein Graft Disease

United States
Lumen Biomedical

Completed

EPIC US Pivotal Study (EPIC)

Percutaneous Intervention of the Carotid Arteries.

United States
Lumen Biomedical

Completed

EPIC European Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

Carotid Artery Stenosis

Germany
Lumen Therapeutics

Terminated

PolyArginine Treated vEiN grafTs (PATENT)

Saphenous Vein Graft Disease

Canada
Lumen Biomedical

Completed

Xtract™ Aspiration Catheter Registry Study

Fresh Soft Emboli or Thrombi in the Arteries.

New Zealand
Lumen Biomedical

Completed

EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting

Carotid Artery Stenosis

United States
Lument AB
LINK Medical Research

Completed

Trial Evaluating the Diagnostic Usefulness of Lumentin® 44 When Used as Contrast Agent

Crohn Disease

Sweden
Lument AB
Q Clinical Research AB

Completed

A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44

Healthy

Sweden
Lumen Bioscience, Inc.
University of Maryland; Naval Medical Research Center; Pharmaron

Completed

LMN-101 in a Campylobacter Human Challenge Model

Campylobacter Infections

United States
Jarding, John, OD
i-Lumen Scientific, Inc.; Professor Timothy Jackson, King's College

Completed

Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration

Age-Related Macular Degeneration | Nonexudative Age-related Macular Degeneration
Clarice Maria de Lucena Martins

Completed

Effect of a Multicomponent Intervention in Children and Adolescents

Metabolic Diseases | Physical Activity
Universidade de Blumenau
Fundacao de Apoio a Pesquisa de Santa Catarina

Completed

Intensification of Care to Improve Adherence to Anti-hypertensives (HyperCare)

Medication Adherence

Brazil
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
VIVA Physicians
Prairie Education and Research Cooperative; Lumen Biomedical

Unknown

Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis (FORTRESS)

Renal Stenting in the Treatment of Pts w/a High Grade Ostial Atherosclerotic Renal Lesion(s).

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
Ximena Goldberg
Universitat Autonoma de Barcelona; La Caixa Foundation; Associació Catalana d...

Unknown

Applied Social Neuroscience: the Building Resilience Among Women Project (BRAW)

Depressive Disorder | Violence, Domestic | Stress Related Disorder

Spain
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan
89bio, Inc.
ProSciento, Inc.

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NASH

United States, Puerto Rico
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States

Clinical Trials Sponsored by Xlumena, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations